References:
- Doshi D, Ben-Yehuda O, Bonafede M, et al. Underutilization of Coronary
Artery Disease Testing Among Patients Hospitalized With New-Onset
Heart Failure. J Am Coll Cardiol. 2016 Aug 2;68(5):450-458. doi:
10.1016/j.jacc.2016.05.060. PMID: 27470451; PMCID: PMC9135048.
- Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for
developing congestive heart failure: the Framingham Heart Study.
Circulation 2002;106:3068–72.
- John JE, Claggett B, Skali H, et al. Coronary Artery Disease and Heart
Failure With Preserved Ejection Fraction: The ARIC Study. J Am Heart
Assoc. 2022 Sep 6;11(17):e021660. doi: 10.1161/JAHA.121.021660. Epub
2022 Aug 24. PMID: 36000416; PMCID: PMC9496411.
- Maddox TM, Januzzi JL Jr, Allen LA, et al. 2021 Update to the 2017 ACC
Expert Consensus Decision Pathway for Optimization of Heart Failure
Treatment: Answers to 10 Pivotal Issues About Heart Failure With
Reduced Ejection Fraction: A Report of the American College of
Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021
Feb 16;77(6):772-810. doi: 10.1016/j.jacc.2020.11.022. Epub 2021 Jan
11. PMID: 33446410.
- Waldo SW, Secemsky EA, O’Brien C, et al. Surgical ineligibility and
mortality among patients with unprotected left main or multivessel
coronary artery disease undergoing percutaneous coronary intervention.
Circulation. 2014 Dec 23;130(25):2295-301. doi:
10.1161/CIRCULATIONAHA.114.011541. Epub 2014 Nov 12. PMID: 25391519;
PMCID: PMC4276481.
- Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of
revascularization on long-term outcome of patients with three-vessel
disease undergoing coronary artery bypass surgery: a report from the
Coronary Artery Surgery Study (CASS) Registry. Circulation
1992;86:446–57.
- Mehta SR, Wood DA, Storey RF, et al. Complete Revascularization with
Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019 Oct
10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1.
PMID: 31475795.
- Farooq V, Serruys PW, Bourantas CV, et al. Quantification of
incomplete revascularization and its association with five-year
mortality in the synergy between percutaneous coronary intervention
with taxus and cardiac surgery (SYNTAX) trial validation of the
residual SYNTAX score. Circulation. 2013 Jul 9;128(2):141-51. doi:
10.1161/CIRCULATIONAHA.113.001803. Epub 2013 Jun 13. PMID: 23766350.
- Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility
trial investigating the use of the Impella 2.5 system in patients
undergoing high-risk percutaneous coronary intervention (The PROTECT I
Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009
Feb;2(2):91-6. doi: 10.1016/j.jcin.2008.11.005. PMID: 19463408.
- O’Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized
clinical trial of hemodynamic support with Impella 2.5 versus
intra-aortic balloon pump in patients undergoing high-risk
percutaneous coronary intervention: the PROTECT II study. Circulation.
2012 Oct 2;126(14):1717-27. doi: 10.1161/CIRCULATIONAHA.112.098194.
Epub 2012 Aug 30. PMID: 22935569.
- Brilakis ES, Banerjee S, Karmpaliotis D, et al. Pro- cedural
outcomes of chronic total occlusion percutaneous coronary
intervention. JACC Cardiovasc Interv 2015;8:245–253.
- Danek BA, Karatasakis A, Karmpaliotis D, et al. Development and
validation of a scoring system for predicting periprocedural
complications during percutaneous coronary interventions of chronic
total occlusions: The Prospective Global Registry for the Study of
Chronic Total Occlusion Intervention (PROGRESS CTO) Complications
Score. J Am Heart Assoc 2016;5:e004272.
- Kostantinis S, Simsek B, Karacsonyi J, et al. In-hospital outcomes and
temporal trends of percutaneous coronary interventions for chronic
total occlusion. EuroIntervention. 2022 Dec 2;18(11):e929-e932. doi:
10.4244/EIJ-D-22-00599. PMID: 36065983; PMCID: PMC9743233.
- Galassi AR, Sianos G, Werner GS, et al. Retrograde Recanalization of
Chronic Total Occlusions in Europe: Procedural, In-Hospital, and
Long-Term Outcomes From the Multicenter ERCTO Registry. J Am Coll
Cardiol 2015; 65:2388.
- Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and
procedural complications in patients undergoing percutaneous coronary
chronic total occlusion interventions: a weighted meta-analysis of
18,061 patients from 65 studies. JACC Cardiovasc Interv 2013; 6:128.
- Grantham JA, Jones PG, Cannon L, Spertus JA. Quantifying the early
health status benefits of successful chronic total occlusion
recanalization: Results from the FlowCardia’s Approach to Chronic
Total Occlusion Recanalization (FACTOR) Trial. Circ Cardiovasc Qual
Outcomes 2010; 3:284.
- Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of
chronic total occlusions: a systematic review and meta-analysis. Am
Heart J 2010; 160:179.
- Sapontis J, Salisbury AC, Yeh RW, et al. Early Procedural and Health
Status Outcomes After Chronic Total Occlusion Angioplasty: A Report
From the OPEN-CTO Registry (Outcomes, Patient Health Status, and
Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC
Cardiovasc Interv 2017; 10:1523.
- Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized
multicentre trial to compare revascularization with optimal medical
therapy for the treatment of chronic total coronary occlusions. Eur
Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220.
PMID: 29722796.
- Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized
multicentre trial to compare revascularization with optimal medical
therapy for the treatment of chronic total coronary occlusions. Eur
Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220.
PMID: 29722796.
- Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or
Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020
Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
PMID: 32227755; PMCID: PMC7263833.
- Achim A, Marc M, Ruzsa Z. Surgical Turned-Downed CHIP Cases-Can PCI
Save the Day? Front Cardiovasc Med. 2022 Apr 7;9:872398. doi:
10.3389/fcvm.2022.872398. PMID: 35463754; PMCID: PMC9021524.
- Perera D, Clayton T, O’Kane PD, et al. REVIVED-BCIS2 Investigators.
Percutaneous Revascularization for Ischemic Left Ventricular
Dysfunction. N Engl J Med. 2022 Oct 13;387(15):1351-1360. doi:
10.1056/NEJMoa2206606. Epub 2022 Aug 27. PMID: 36027563.
- Wollmuth J, Patel MP, Dahle T, Bharadwaj A, Waggoner TE, Chambers JW,
et al. Ejection fraction improvement following contemporary high-risk
percutaneous coronary intervention: Restore EF Study results. Journal
of the Society for Cardiovascular Angiography & Interventions.
2022;1(5):100350. doi:10.1016/j.jscai.2022.100350